Expanding Data Access OneMedNet’s breakthrough platform has recently gone live with access to over 80 million patient journeys and billions of clinical records, providing a vast, scalable data resource that can support pharmaceutical companies, medical device developers, and AI-driven healthcare startups seeking comprehensive real-world data solutions.

Strong Regulatory Focus The company’s emphasis on delivering regulatory decision-grade and AI-ready data positions it as a vital partner for firms aiming to meet compliance requirements, enhance post-market surveillance, and accelerate regulatory submissions with high-quality, de-identified clinical data.

Collaborative Initiatives Recent strategic collaborations in oncology and pharma underscore OneMedNet’s ability to support specialized research and drug development efforts, offering tailored data solutions for precision medicine and accelerating clinical trial recruitment and analysis.

Innovative Technology Powered by Palantir Foundry, the company’s platform leverages AI and advanced search capabilities to enable real-time, conversational data access, creating opportunities to engage clients interested in cutting-edge data analytics and machine learning applications for healthcare insights.

Growth Opportunities With a demonstrated customer conversion following successful platform demonstrations at major tradeshows, OneMedNet shows promising potential for expanding its subscription base among large pharmaceutical and healthcare organizations seeking scalable, data-driven decision support tools.